Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | CCNC | P24863 | 1/20 | 0.31 |
| ▸ | CDK8 | P49336 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4361731 | 0.88 | L3MBTL1 (0.32) | ALDH1A1L3MBTL1MEN1KMT2AEGFR | |
| SCHEMBL10138023 | 0.88 | TSHR (0.37) | ALDH1A1MAPTMEN1KMT2AHSP90B1 | |
| SCHEMBL2348285 | 0.88 | PBRM1 (0.36) | L3MBTL1POLBMEN1KMT2AHSP90B1 | |
| SCHEMBL4358865 | 0.86 | ALDH1A1 (0.36) | ALDH1A1KDM4EL3MBTL1MAPTPOLB | |
| SCHEMBL4011884 | 0.85 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1MEN1KMT2AMAPK1 | |
| SCHEMBL4011696 | 0.85 | KMT2A (0.41) | ALDH1A1L3MBTL1POLBMEN1KMT2A | |
| SCHEMBL4356056 | 0.83 | L3MBTL1 (0.34) | ALDH1A1KDM4EHSD17B10L3MBTL1MAPT | |
| SCHEMBL4358008 | 0.78 | ALDH1A1 (0.34) | ALDH1A1L3MBTL1MAPK1 | |
| SCHEMBL4012367 | 0.77 | ACLY (0.35) | ALDH1A1HSP90B1MAPK1HSP90AA1CCNC | |
| SCHEMBL14458606 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7601851-B2 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2009-10-13 | — | — | US | disclosed |
| US-7112684-B2 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2006-09-26 | — | — | US | disclosed |
| US-20050277144-A1 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-12-15 | — | — | US | disclosed |
| US-6972339-B2 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-12-06 | — | — | US | disclosed |
| US-20050176066-A1 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-08-11 | — | — | US | disclosed |
| US-20050171340-A1 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES, INC. (US) | 2005-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176066-A1 | Compounds and methods for fluorescent labeling | HLCS, GLB1, TUBB | DPP4 2575/4885ALDH1A1 218/4885KDM4E 3500/4885 |
| US-20050171340-A1 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | HLCS, GLB1, TUBB | DPP4 2575/4885ALDH1A1 218/4885KDM4E 3500/4885 |
| US-20050277144-A1 | Compounds and methods for fluorescent labeling | HLCS, GLB1, TUBB | DPP4 2575/4885ALDH1A1 218/4885KDM4E 3500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.